Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000950170-24-007422

Options or other derivatives

  • Chief Legal Officer acquired 255,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kearns Evan Chief Legal Officer 2024-01-23 Grant or award · Stock Option (Right to Buy) +255,000 255,000 D
Loading xslF345X05/ownership.xml…